A J Church1, R C Dale, G Giovannoni. 1. Neuroinflammation Department, Institute of Neurology, Queen Square, London, UK WC1N 3BG. A.Church@ion.ucl.ac.uk
Abstract
BACKGROUND: The spectrum of post-streptococcal brain disorders includes chorea, tics, and dystonia. The proposed mediators of disease are anti-basal ganglia (neuronal) antibodies (ABGA). AIM: To evaluate ABGA as a potential diagnostic marker in a cohort of UK post-streptococcal movement disorders. METHODS: Forty UK children presenting with movement disorders associated with streptococcal infection were recruited. ABGA was measured using ELISA and Western immunoblotting. To determine ABGA specificity and sensitivity, children with neurological diseases (n = 100), children with uncomplicated streptococcal infection (n = 40), and children with autoimmune disease (n = 50) were enrolled as controls. RESULTS: The mean ELISA result was increased in the post-streptococcal movement disorder group compared to all controls and derived a sensitivity of 82.4% and specificity of 79%. The Western immunoblotting method to detect ABGA derived a sensitivity and specificity of 92.5% and 94.7% respectively. There was common binding to basal ganglia antigens of 40, 45, and 60 kDa. Immunofluorescence localised the antibody binding to basal ganglia neurones. CONCLUSION: ABGA appears to be a potentially useful diagnostic marker in post-streptococcal neurological disorders. Western immunoblotting appears to be the preferred method due to good sensitivity and specificity and the ability to test several samples at once.
BACKGROUND: The spectrum of post-streptococcal brain disorders includes chorea, tics, and dystonia. The proposed mediators of disease are anti-basal ganglia (neuronal) antibodies (ABGA). AIM: To evaluate ABGA as a potential diagnostic marker in a cohort of UK post-streptococcal movement disorders. METHODS: Forty UK children presenting with movement disorders associated with streptococcal infection were recruited. ABGA was measured using ELISA and Western immunoblotting. To determine ABGA specificity and sensitivity, children with neurological diseases (n = 100), children with uncomplicated streptococcal infection (n = 40), and children with autoimmune disease (n = 50) were enrolled as controls. RESULTS: The mean ELISA result was increased in the post-streptococcal movement disorder group compared to all controls and derived a sensitivity of 82.4% and specificity of 79%. The Western immunoblotting method to detect ABGA derived a sensitivity and specificity of 92.5% and 94.7% respectively. There was common binding to basal ganglia antigens of 40, 45, and 60 kDa. Immunofluorescence localised the antibody binding to basal ganglia neurones. CONCLUSION: ABGA appears to be a potentially useful diagnostic marker in post-streptococcal neurological disorders. Western immunoblotting appears to be the preferred method due to good sensitivity and specificity and the ability to test several samples at once.
Authors: Jane R Taylor; Syed A Morshed; Salina Parveen; Marcos T Mercadante; Lawrence Scahill; Bradley S Peterson; Robert A King; James F Leckman; Paul J Lombroso Journal: Am J Psychiatry Date: 2002-04 Impact factor: 18.112
Authors: S A Morshed; S Parveen; J F Leckman; M T Mercadante; M H Bittencourt Kiss; E C Miguel; A Arman; Y Yazgan; T Fujii; S Paul; B S Peterson; H Zhang; R A King; L Scahill; P J Lombroso Journal: Biol Psychiatry Date: 2001-10-15 Impact factor: 13.382
Authors: R C Dale; A J Church; F Cardoso; E Goddard; T C Cox; W K Chong; A Williams; N J Klein; B G Neville; E J Thompson; G Giovannoni Journal: Ann Neurol Date: 2001-11 Impact factor: 10.422
Authors: Russell C Dale; Andrew J Church; Sarah Benton; Robert A Surtees; Andrew Lees; Edward J Thompson; Gavin Giovannoni; Brian G Neville Journal: Dev Med Child Neurol Date: 2002-07 Impact factor: 5.449
Authors: R C Dale; I Heyman; R A H Surtees; A J Church; G Giovannoni; R Goodman; B G R Neville Journal: Arch Dis Child Date: 2004-07 Impact factor: 3.791
Authors: I Marschitz; S Rödl; U Gruber-Sedlmayr; A Church; G Giovannoni; G Zobel; C J Mache; J Raith; B Plecko Journal: J Neurol Neurosurg Psychiatry Date: 2007-01 Impact factor: 10.154
Authors: Borwin Bandelow; David Baldwin; Marianna Abelli; Blanca Bolea-Alamanac; Michel Bourin; Samuel R Chamberlain; Eduardo Cinosi; Simon Davies; Katharina Domschke; Naomi Fineberg; Edna Grünblatt; Marek Jarema; Yong-Ku Kim; Eduard Maron; Vasileios Masdrakis; Olya Mikova; David Nutt; Stefano Pallanti; Stefano Pini; Andreas Ströhle; Florence Thibaut; Matilde M Vaghi; Eunsoo Won; Dirk Wedekind; Adam Wichniak; Jade Woolley; Peter Zwanzger; Peter Riederer Journal: World J Biol Psychiatry Date: 2016-07-15 Impact factor: 4.132
Authors: Ivana Kawikova; Bart P X Grady; Zuzana Tobiasova; Yan Zhang; Aristo Vojdani; Liliya Katsovich; Brian J Richmand; Tae Won Park; Alfred L M Bothwell; James F Leckman Journal: Biol Psychiatry Date: 2009-12-14 Impact factor: 13.382
Authors: Davide Martino; Russell C Dale; Donald L Gilbert; Gavin Giovannoni; James F Leckman Journal: Mov Disord Date: 2009-07-15 Impact factor: 10.338
Authors: R C Dale; I Heyman; R A H Surtees; A J Church; G Giovannoni; R Goodman; B G R Neville Journal: Arch Dis Child Date: 2004-07 Impact factor: 3.791